Best treatment for multiple sclerosis may be antivirals

Research suggests antivirals targeting the Epstein-Barr virus (EBV) may be the most effective treatment for multiple sclerosis (MS). Studies found people with MS produce twice as many CD4 T-cells targeting proteins from actively replicating EBV compared to those without MS, indicating a distinct immune response. Researchers urge pharmaceutical companies to develop EBV-specific antiviral drugs for future MS therapy.